Blackthorn Therapeutics

Developer of therapeutics for neurodevelopmental disorders

placeSan Francisco, California, United States calendar_todayFounded 2014 groups38 employees language blackthornrx.com

Innovation

13 patent families (8 granted) — focus: Chemistry & metallurgy, Physics & computing, Human necessities; filing pace slowing. Cited 706 times.

YearFilings
20182
20195
202010
202110
20227
20237
20245
20251

Investor mix

11 investors on record; lead investors include Polaris Partners, Scripps Research, Premier Partners, Vertex Ventures HC; 1 has since exited.

Investor typeCountShare
Venture capital873%
Private equity19%
Other / undisclosed218%
Coming soon